产品详情
简单介绍：
Anti-FXYD7抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-FXYD7抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-FXYD7
Cat. Number:
Anti-FXYD7抗体KL-13235R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This reference sequence was derived from multiple replicate ESTs and validated by similar human genomic sequence. This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conservedAnti-FXYD7抗体 amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. This gene product, FXYD7, is novel and has not been characterized as a protein. [RefSeq curation by Kathleen J. Sweadner, Ph.D., sweadner@helix.mgh.harvard.edu., Dec 2000].
Also known as:
FLJ25096; FXYD domain containing ion Anti-FXYD7抗体transport regulator 7; FXYD domain-containing ion transport regulator 7; Fxyd7; FXYD7_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Cow, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human FXYD7.
●
Predicted Molecular Weight: Anti-FXYD7抗体9kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-FXYD7抗体
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-FXYD7抗体
Optimal working dilutions must be determined by the end user.
kl553Mu01 基质金属蛋白酶9(MMP9)多克隆抗体 Polyclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
kl553Po01 基质金属蛋白酶9(MMP9)多克隆抗体 Polyclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
kl553Ra01 基质金属蛋白酶9(MMP9)多克隆抗体 Polyclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
kl554Ra01 尼克酰胺腺嘌呤二核苷酸磷酸氧化酶1(NOX1)多克隆抗体 Polyclonal Antibody to Nicotinamide Adenine Dinucleotide Phosphate Oxidase 1 (NOX1)
kl556Hu01 角蛋白7(KRT7)多克隆抗体 Polyclonal Antibody to Keratin 7 (KRT7)
kl557Hu01 甲状腺过氧化物酶(TPO)多克隆抗体 Polyclonal Antibody to Thyroid Peroxidase (TPO)
kl557Ra01 甲状腺过氧化物酶(TPO)多克隆抗体 Polyclonal Antibody to Thyroid Peroxidase (TPO)
kl558Hu01 端粒酶关联蛋白1(TEP1)多克隆抗体 Polyclonal Antibody to Telomerase Associated Protein 1 (TEP1)
kl559Hu01 肠型脂肪酸结合蛋白(FABP2)多克隆抗体 Polyclonal Antibody to Fatty Acid Binding Protein 2, Intestinal (FABP2)
kl559Mu01 肠型脂肪酸结合蛋白(FABP2)多克隆抗体 Polyclonal Antibody to Fatty Acid Binding Protein 2, Intestinal (FABP2)
kl559Ra01 肠型脂肪酸结合蛋白(FABP2)多克隆抗体 Polyclonal Antibody to Fatty Acid Binding Protein 2, Intestinal (FABP2)
kl561Mu01 白血病抑制因子受体(LIFR)多克隆抗体 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl561Ra01 白血病抑制因子受体(LIFR)多克隆抗体 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl563Bo01 白介素1β(IL1β)多克隆抗体 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
kl563Ca01 白介素1β(IL1β)多克隆抗体 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
kl563Eq01 白介素1β(IL1β)多克隆抗体 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
kl563Ga01 白介素1β(IL1β)多克隆抗体 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
kl563Gu01 白介素1β(IL1β)多克隆抗体 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
